Dapagliflozin in Type 1 Diabetes

Clinical trial NCT02211742 · COMPLETED

Trial details

NCT number: NCT02211742
Sponsor: Medical University Innsbruck
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Fasting Glucose Glucose Excursion Glycemic Control

Start date: 2014-08-01
Primary completion: 2016-07-29
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.